Editorial: Type 2 diabetes and cancer: clinical and molecular interactions

Editorial: Type 2 diabetes and cancer: clinical and molecular interactions

Detalhes bibliográficos
Main Authors:	Mariachiara Santorsola, Michele Caraglia, Alessandro Ottaiano
Formato:	Artigo
Idioma:	English
Publicado em:	Frontiers Media S.A. 2024-01-01
Colecção:	Frontiers in Medicine
Assuntos:	diabetes genetics cancer p53 lung cancer glioma
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1345732/full

Registos relacionados

P53 mRNA in- Situ Hybridization analysis and Immunohistochemical Expression in Lung Cancer: A Comparative Study.
Por: Ban A. Abdul-Majeed
Publicado em: (2010-10-01)

The role of SNPs in the management of cancer in the broader population
Por: Kitchen-Smith, I
Publicado em: (2020)

Editorial: Recent advances in the molecular genetics of glioma
Por: Caroline Chung, et al.
Publicado em: (2024-07-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
Por: Ilay Caliskan, et al.
Publicado em: (2024-03-01)

p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications
Por: Dixan A. Benitez, et al.
Publicado em: (2024-06-01)

Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization
Por: Rachelle P. Mendoza, et al.
Publicado em: (2024-01-01)

Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
Por: Wenshu Li, et al.
Publicado em: (2024-07-01)

Immunohitochemical expression of p53 in human colocrectal carcinoma
Por: Sazan abdulwahab Mirza, et al.
Publicado em: (2016-10-01)

Clinical and Immunological Effects of p53-Targeting Vaccines
Por: Shan Zhou, et al.
Publicado em: (2021-11-01)

Integrated analysis of cell cycle and p53 signaling pathways related genes in breast, colorectal, lung, and pancreatic cancers: implications for prognosis and drug sensitivity for therapeutic potential
Por: Jiyauddin Khan, et al.
Publicado em: (2024-12-01)

CENPF as a prognostic marker of glioma: unraveling the molecular mechanisms
Por: Xiuyang Chen, et al.
Publicado em: (2025-02-01)

Demethylzeylasteral exerts potent efficacy against non-small-cell lung cancer via the P53 signaling pathway
Por: Linxi Lv, et al.
Publicado em: (2024-08-01)

Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies
Por: Miriana Cardano, et al.
Publicado em: (2025-02-01)

Decreased expression of p53 is associated with down expression of zyxin in breast cancer
Por: Rezvan Rostampour, et al.
Publicado em: (2024-08-01)

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
Por: Lin W, et al.
Publicado em: (2024-01-01)

IGF2: The Achilles' heel of p53‐deficiency?
Por: Frederic Clermont, et al.
Publicado em: (2012-07-01)

Effect of extracellular vesicle ZNF280B derived from lung cancer stem cells on lung cancer progression
Por: Qixia Guo, et al.
Publicado em: (2025-12-01)

Molecular Dynamics Simulation of the Interaction of Saccharin with Human p53 Protein
Por: M Shahlai, et al.
Publicado em: (2023-12-01)

IDENTIFICATION OF POLYMORPHOUS VARIANTS OF GENES REGULATING CELLULAR CYCLE IN CASE OF LUNG CANCER
Por: A. I. Dmitrieva, et al.
Publicado em: (2015-10-01)

A comprehensive view on the fisetin impact on colorectal cancer in animal models: Focusing on cellular and molecular mechanisms
Por: Mohammad Yasin Zamanian, et al.
Publicado em: (2024-10-01)

MRI-based model for accurate prediction of P53 gene status in gliomas
Por: Yulin Zhao, et al.
Publicado em: (2024-04-01)

2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Induces Antimitogenic and Apoptotic Actions in Oligodendroglial Precursor Cells and Triggers Endoreduplication via the p53 Pathway
Por: Sara. A. Schaufelberger, et al.
Publicado em: (2024-06-01)

Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
Por: Cristina Trejo-Solís, et al.
Publicado em: (2024-04-01)

The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53–MDM2 Modulation
Por: Adel S. Girgis, et al.
Publicado em: (2025-02-01)

Proteomic Analysis Shows Constitutive Secretion of MIF and p53-associated Activity of COX-2−/− Lung Fibroblasts
Por: Mandar Dave, et al.
Publicado em: (2017-12-01)

Lack of telomerase reduces cancer incidence and increases lifespan of zebrafish tp53 M214K mutants
Por: Naz Şerifoğlu, et al.
Publicado em: (2024-03-01)

The Expression, Morphology, and Clinical Characteristics of Fibroblast Growth Factor-10 in Breast Cancer
Por: Samira Molashahi, et al.
Publicado em: (2021-10-01)

Cisplatin and Paclitaxel Modulated the Cell Survival Potential of Prostate Cancer Cells
Por: Sina Kashani, et al.
Publicado em: (2020-01-01)

Molecular dynamics-based computational investigations on the influence of tumor suppressor p53 binding protein against other proteins/peptides
Por: Mohnad Abdalla, et al.
Publicado em: (2024-12-01)

SP-8356: A Novel Verbenone Derivative Exerts In Vitro Anti-Non-Small Cell Lung Cancer Effects, Promotes Apoptosis via The P53/MDM2 Axis and Inhibits Tumor Formation in Mice
Por: Lei Yang, et al.
Publicado em: (2023-12-01)

A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
Por: Bohao Zhang, et al.
Publicado em: (2025-01-01)

Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol
Por: Miriam Dixon-Zegeye, et al.
Publicado em: (2024-02-01)

Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies
Por: Jolanda Magri, et al.
Publicado em: (2021-01-01)

The role of BET attenuation in melanoma
Por: Henderson, EK
Publicado em: (2020)

High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report
Por: Paola Giancontieri, et al.
Publicado em: (2024-02-01)

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability
Por: YiQing Lü, et al.
Publicado em: (2024-04-01)

UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma
Por: Zhou Kun, et al.
Publicado em: (2024-04-01)

Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study
Por: Erlend Skaga, et al.
Publicado em: (2024-03-01)

Histologic and immunohistochemical evaluation of mirror image biopsies in oral squamous cell carcinoma
Por: Vineet Gupta, et al.
Publicado em: (2016-09-01)

Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers
Por: Daniela Tosoni, et al.
Publicado em: (2017-03-01)